Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells

Authors: Bing Chen, Yuling Liu, Xuewen Jin, Weiliang Lu, Jingjing Liu, Zijing Xia, Qiong Yuan, Xia Zhao, Ningzhi Xu, Shufang Liang

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Reprogramming energy metabolism has been an emerging hallmark of cancer cells. MicroRNAs play important roles in glucose metabolism.

Methods

The targets of microRNA-26a (miR-26a) were predicted by bioinformatics tools. The efficacy of miR-26a binding the 3′-untranslated region (UTR) of pyruvate dehydrogenase protein X component (PDHX) mRNA was evaluated using a dual-luciferase reporter assay. The PDHX expression at the mRNA and protein level in several colon cancer cell lines was quantified with real-time PCR and Western blot analysis respectively. The effects of miR-26a on glucose metabolism were determined by detecting the content of glucose consumption, production of lactate, pyruvate, and acetyl-coenzyme A.

Results

The expression of miR-26a is inversely associated with the level of its targeting protein PDHX in several colon cancer cell lines with different malignancy potentials. MiR-26a inhibits PDHX expression by direct targeting the 3′-UTR of PDHX mRNA. The glucose consumption and lactate concentration were both greatly increased in colon cancer cells than the normal colon mucosal epithelia under physiological conditions. The overexpression of miR-26a in HCT116 cells efficiently improved the accumulation of pyruvate and decreased the production of acetyl coenzyme A. Meanwhile the inhibition of miR-26a expression induced inverse biological effects.

Conclusions

MiR-26a regulates glucose metabolism of colorectal cancer cells by direct targeting the PDHX, which inhibits the conversion of pyruvate to acetyl coenzyme A in the citric acid cycle.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S: Roles of microRNA on cancer cell metabolism. J Transl Med. 2012, 10 (1): 228-10.1186/1479-5876-10-228.CrossRefPubMedPubMedCentral Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S: Roles of microRNA on cancer cell metabolism. J Transl Med. 2012, 10 (1): 228-10.1186/1479-5876-10-228.CrossRefPubMedPubMedCentral
2.
go back to reference Pucci S, Mazzarelli P: MicroRNA dysregulation in colon cancer microenvironment interactions: the importance of small things in metastases. Cancer Microenviron. 2011, 4 (2): 155-162. 10.1007/s12307-011-0062-y.CrossRefPubMedPubMedCentral Pucci S, Mazzarelli P: MicroRNA dysregulation in colon cancer microenvironment interactions: the importance of small things in metastases. Cancer Microenviron. 2011, 4 (2): 155-162. 10.1007/s12307-011-0062-y.CrossRefPubMedPubMedCentral
3.
go back to reference Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, Feng Y, Li L, Wang Y, Liu X, Chen H, Liu X, Ji H: MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem. 2012, 287 (27): 23227-23235. 10.1074/jbc.M112.373084.CrossRefPubMedPubMedCentral Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, Feng Y, Li L, Wang Y, Liu X, Chen H, Liu X, Ji H: MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem. 2012, 287 (27): 23227-23235. 10.1074/jbc.M112.373084.CrossRefPubMedPubMedCentral
4.
5.
go back to reference Fei X, Qi M, Wu B, Song Y, Wang Y, Li T: MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett. 2012, 586 (4): 392-397. 10.1016/j.febslet.2012.01.006.CrossRefPubMed Fei X, Qi M, Wu B, Song Y, Wang Y, Li T: MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett. 2012, 586 (4): 392-397. 10.1016/j.febslet.2012.01.006.CrossRefPubMed
6.
go back to reference Peschiaroli A, Giacobbe A, Formosa A, Markert EK, Bongiorno-Borbone L, Levine AJ, Candi E, D’Alessandro A, Zolla L, Finazzi Agro A, Melino G: miR-143 regulates hexokinase 2 expression in cancer cells. Oncogene. 2013, 32 (6): 797-802. 10.1038/onc.2012.100.CrossRefPubMed Peschiaroli A, Giacobbe A, Formosa A, Markert EK, Bongiorno-Borbone L, Levine AJ, Candi E, D’Alessandro A, Zolla L, Finazzi Agro A, Melino G: miR-143 regulates hexokinase 2 expression in cancer cells. Oncogene. 2013, 32 (6): 797-802. 10.1038/onc.2012.100.CrossRefPubMed
7.
go back to reference Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T, Braun T, Seibler J, Brüning JC: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011, 13 (4): 434-446. 10.1038/ncb2211.CrossRefPubMed Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T, Braun T, Seibler J, Brüning JC: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011, 13 (4): 434-446. 10.1038/ncb2211.CrossRefPubMed
8.
go back to reference Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016/j.cell.2011.02.013.CrossRefPubMed Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016/j.cell.2011.02.013.CrossRefPubMed
9.
go back to reference Cairns RA, Harris IS, Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer. 2011, 11 (2): 85-95. 10.1038/nrc2981.CrossRefPubMed Cairns RA, Harris IS, Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer. 2011, 11 (2): 85-95. 10.1038/nrc2981.CrossRefPubMed
10.
go back to reference Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006, 103 (7): 2257-2261. 10.1073/pnas.0510565103.CrossRefPubMedPubMedCentral Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006, 103 (7): 2257-2261. 10.1073/pnas.0510565103.CrossRefPubMedPubMedCentral
11.
go back to reference Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M: A microRNA signature of hypoxia. Mol Cell Biol. 2007, 27 (5): 1859-1867. 10.1128/MCB.01395-06.CrossRefPubMedPubMedCentral Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M: A microRNA signature of hypoxia. Mol Cell Biol. 2007, 27 (5): 1859-1867. 10.1128/MCB.01395-06.CrossRefPubMedPubMedCentral
12.
go back to reference Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 2011, 32 (1): 2-9. 10.1093/carcin/bgq209.CrossRefPubMed Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ, Zhao Q: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 2011, 32 (1): 2-9. 10.1093/carcin/bgq209.CrossRefPubMed
13.
go back to reference Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C, Cai Z: Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol Ther. 2011, 19 (8): 1521-1528. 10.1038/mt.2011.64.CrossRefPubMedPubMedCentral Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C, Cai Z: Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol Ther. 2011, 19 (8): 1521-1528. 10.1038/mt.2011.64.CrossRefPubMedPubMedCentral
14.
go back to reference Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM: MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol. 2011, 226 (4): 1035-1043. 10.1002/jcp.22422.CrossRefPubMedPubMedCentral Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM: MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol. 2011, 226 (4): 1035-1043. 10.1002/jcp.22422.CrossRefPubMedPubMedCentral
15.
go back to reference Liu B, Wu X, Wang C, Liu Y, Zhou Q, Xu K: MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 2012, 1822 (11): 1692-1704. 10.1016/j.bbadis.2012.07.019.CrossRefPubMed Liu B, Wu X, Wang C, Liu Y, Zhou Q, Xu K: MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 2012, 1822 (11): 1692-1704. 10.1016/j.bbadis.2012.07.019.CrossRefPubMed
16.
go back to reference Altenberg B, Greulich KO: Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics. 2004, 84 (6): 1014-1020. 10.1016/j.ygeno.2004.08.010.CrossRefPubMed Altenberg B, Greulich KO: Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics. 2004, 84 (6): 1014-1020. 10.1016/j.ygeno.2004.08.010.CrossRefPubMed
17.
go back to reference Alcarraz-Vizan G, Sanchez-Tena S, Moyer MP, Cascante M: Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: Trichostatin A as a case study. Biochim Biophys Acta. 2013, 1840 (6): 1634-1639.CrossRefPubMed Alcarraz-Vizan G, Sanchez-Tena S, Moyer MP, Cascante M: Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: Trichostatin A as a case study. Biochim Biophys Acta. 2013, 1840 (6): 1634-1639.CrossRefPubMed
18.
go back to reference Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 2005, 37 (5): 495-500. 10.1038/ng1536.CrossRefPubMed Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 2005, 37 (5): 495-500. 10.1038/ng1536.CrossRefPubMed
19.
go back to reference Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S, Li B, Li Y, Li D, Wang ED, Liu MF: A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J. 2012, 31 (8): 1985-1998. 10.1038/emboj.2012.45.CrossRefPubMedPubMedCentral Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S, Li B, Li Y, Li D, Wang ED, Liu MF: A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J. 2012, 31 (8): 1985-1998. 10.1038/emboj.2012.45.CrossRefPubMedPubMedCentral
20.
go back to reference Sze CW, Li C: Inactivation of bb0184, which encodes carbon storage regulator A, represses the infectivity of Borrelia burgdorferi. Infect Immun. 2011, 79 (3): 1270-1279. 10.1128/IAI.00871-10.CrossRefPubMed Sze CW, Li C: Inactivation of bb0184, which encodes carbon storage regulator A, represses the infectivity of Borrelia burgdorferi. Infect Immun. 2011, 79 (3): 1270-1279. 10.1128/IAI.00871-10.CrossRefPubMed
21.
go back to reference Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim. 1996, 32 (6): 315-317. 10.1007/BF02722955.CrossRefPubMed Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim. 1996, 32 (6): 315-317. 10.1007/BF02722955.CrossRefPubMed
22.
go back to reference Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M: Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A. 1994, 91 (14): 6319-6323. 10.1073/pnas.91.14.6319.CrossRefPubMedPubMedCentral Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M: Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A. 1994, 91 (14): 6319-6323. 10.1073/pnas.91.14.6319.CrossRefPubMedPubMedCentral
23.
go back to reference Xue H, Lü B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M: Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res. 2009, 9 (1): 545-555.CrossRef Xue H, Lü B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M: Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res. 2009, 9 (1): 545-555.CrossRef
24.
go back to reference Tajir M, Arnoux JB, Boutron A, Elalaoui SC, De Lonlay P, Sefiani A, Brivet M: Pyruvate dehydrogenase deficiency caused by a new mutation of PDHX gene in two Moroccan patients. Eur J Med Genet. 2012, 55 (10): 535-540. 10.1016/j.ejmg.2012.06.006.CrossRefPubMed Tajir M, Arnoux JB, Boutron A, Elalaoui SC, De Lonlay P, Sefiani A, Brivet M: Pyruvate dehydrogenase deficiency caused by a new mutation of PDHX gene in two Moroccan patients. Eur J Med Genet. 2012, 55 (10): 535-540. 10.1016/j.ejmg.2012.06.006.CrossRefPubMed
25.
go back to reference Mine M, Brivet M, Schiff M, de Baulny HO, Chuzhanova N, Marsac C: A novel gross deletion caused by non-homologous recombination of the PDHX gene in a patient with pyruvate dehydrogenase deficiency. Mol Genet Metab. 2006, 89 (1–2): 106-110.CrossRefPubMed Mine M, Brivet M, Schiff M, de Baulny HO, Chuzhanova N, Marsac C: A novel gross deletion caused by non-homologous recombination of the PDHX gene in a patient with pyruvate dehydrogenase deficiency. Mol Genet Metab. 2006, 89 (1–2): 106-110.CrossRefPubMed
26.
go back to reference Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23 (11): 1327-1337. 10.1101/gad.1777409.CrossRefPubMedPubMedCentral Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23 (11): 1327-1337. 10.1101/gad.1777409.CrossRefPubMedPubMedCentral
27.
go back to reference Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX: MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 2013, 58 (1): 158-170. 10.1002/hep.26305.CrossRefPubMed Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX: MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 2013, 58 (1): 158-170. 10.1002/hep.26305.CrossRefPubMed
28.
go back to reference Stacpoole PW: The pyruvate dehydrogenase complex as a therapeutic target for age‒related diseases. Aging Cell. 2012, 11: 371-377. 10.1111/j.1474-9726.2012.00805.x.CrossRefPubMed Stacpoole PW: The pyruvate dehydrogenase complex as a therapeutic target for age‒related diseases. Aging Cell. 2012, 11: 371-377. 10.1111/j.1474-9726.2012.00805.x.CrossRefPubMed
29.
go back to reference Margineantu DH, Brown RM, Brown GK, Marcus AH, Capaldi RA: Heterogeneous distribution of pyruvate dehydrogenase in the matrix of mitochondria. Mitochondrion. 2002, 1 (4): 327-338. 10.1016/S1567-7249(01)00033-2.CrossRefPubMed Margineantu DH, Brown RM, Brown GK, Marcus AH, Capaldi RA: Heterogeneous distribution of pyruvate dehydrogenase in the matrix of mitochondria. Mitochondrion. 2002, 1 (4): 327-338. 10.1016/S1567-7249(01)00033-2.CrossRefPubMed
30.
go back to reference Thorens B, Mueckler M: Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab. 2010, 298: E141-E145. 10.1152/ajpendo.00712.2009.CrossRefPubMed Thorens B, Mueckler M: Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab. 2010, 298: E141-E145. 10.1152/ajpendo.00712.2009.CrossRefPubMed
31.
go back to reference Fiaschi T, Marini A, Giannoni E, Taddei M, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P: Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012, 72: 5130-5140. 10.1158/0008-5472.CAN-12-1949.CrossRefPubMed Fiaschi T, Marini A, Giannoni E, Taddei M, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P: Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012, 72: 5130-5140. 10.1158/0008-5472.CAN-12-1949.CrossRefPubMed
32.
go back to reference Fiaschi T, Giannoni E, Taddei M, Cirri P, Marini A, Pintus G, Nativi C, Richichi B, Scozzafava A, Carta F, Torre E, Supuran CT, Chiarugi P: Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle. 2013, 12: 1791-1801. 10.4161/cc.24902.CrossRefPubMedPubMedCentral Fiaschi T, Giannoni E, Taddei M, Cirri P, Marini A, Pintus G, Nativi C, Richichi B, Scozzafava A, Carta F, Torre E, Supuran CT, Chiarugi P: Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle. 2013, 12: 1791-1801. 10.4161/cc.24902.CrossRefPubMedPubMedCentral
33.
go back to reference Jansson MD, Lund AH: MicroRNA and cancer. Mol Oncol. 2012, 6 (6): 590-610. 10.1016/j.molonc.2012.09.006.CrossRefPubMed Jansson MD, Lund AH: MicroRNA and cancer. Mol Oncol. 2012, 6 (6): 590-610. 10.1016/j.molonc.2012.09.006.CrossRefPubMed
34.
go back to reference Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010, 327 (5962): 198-201. 10.1126/science.1178178.CrossRefPubMed Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010, 327 (5962): 198-201. 10.1126/science.1178178.CrossRefPubMed
35.
go back to reference Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S: Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012, 3 (1): 1-10.1186/1758-907X-3-1.CrossRefPubMedPubMedCentral Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S: Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012, 3 (1): 1-10.1186/1758-907X-3-1.CrossRefPubMedPubMedCentral
36.
go back to reference Rossi JJ: New hope for a microRNA therapy for liver cancer. Cell. 2009, 137 (6): 990-992. 10.1016/j.cell.2009.05.038.CrossRefPubMed Rossi JJ: New hope for a microRNA therapy for liver cancer. Cell. 2009, 137 (6): 990-992. 10.1016/j.cell.2009.05.038.CrossRefPubMed
37.
go back to reference Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM: Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013, 18 (5–6): 282-289.CrossRefPubMed Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM: Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013, 18 (5–6): 282-289.CrossRefPubMed
38.
go back to reference El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E: miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 2008, 57 (10): 2708-2717. 10.2337/db07-1614.CrossRefPubMedPubMedCentral El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E: miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 2008, 57 (10): 2708-2717. 10.2337/db07-1614.CrossRefPubMedPubMedCentral
39.
go back to reference Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, Jonneaux A, Ballot C, Balayssac S, Valable S, Corroyer-Dulmont A, Bernaudin M, Malet-Martino M, de Lassalle EM, Maboudou P, Formstecher P, Polakowska R, Mortier L, Marchetti P: Inactivation of the HIF-1alpha/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res. 2012, 72 (19): 5035-5047. 10.1158/0008-5472.CAN-12-0979.CrossRefPubMed Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, Jonneaux A, Ballot C, Balayssac S, Valable S, Corroyer-Dulmont A, Bernaudin M, Malet-Martino M, de Lassalle EM, Maboudou P, Formstecher P, Polakowska R, Mortier L, Marchetti P: Inactivation of the HIF-1alpha/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res. 2012, 72 (19): 5035-5047. 10.1158/0008-5472.CAN-12-0979.CrossRefPubMed
40.
go back to reference Iorio MV, Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012, 4 (3): 143-159. 10.1002/emmm.201100209.CrossRefPubMedPubMedCentral Iorio MV, Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012, 4 (3): 143-159. 10.1002/emmm.201100209.CrossRefPubMedPubMedCentral
41.
go back to reference Boni V, Zarate R, Villa JC, Bandres E, Gomez MA, Maiello E, Garcia-Foncillas J, Aranda E: Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J. 2011, 11 (6): 429-436. 10.1038/tpj.2010.58.CrossRefPubMed Boni V, Zarate R, Villa JC, Bandres E, Gomez MA, Maiello E, Garcia-Foncillas J, Aranda E: Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J. 2011, 11 (6): 429-436. 10.1038/tpj.2010.58.CrossRefPubMed
42.
go back to reference Di Leva G, Briskin D, Croce CM: MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci. 2012, 117 (2): 202-216. 10.3109/03009734.2012.660551.CrossRefPubMedPubMedCentral Di Leva G, Briskin D, Croce CM: MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci. 2012, 117 (2): 202-216. 10.3109/03009734.2012.660551.CrossRefPubMedPubMedCentral
Metadata
Title
MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells
Authors
Bing Chen
Yuling Liu
Xuewen Jin
Weiliang Lu
Jingjing Liu
Zijing Xia
Qiong Yuan
Xia Zhao
Ningzhi Xu
Shufang Liang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-443

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine